The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19–9 in Pancreatic Cancer Diagnosis

PURPOSE: The CA19–9 biomarker is elevated in a substantial group of patients with pancreatic ductal adenocarcinoma (PDAC), but not enough to be reliable for the detection or diagnosis of the disease. We hypothesized that a glycan called sTRA (sialylated tumor-related antigen) is a biomarker for PDAC...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Clin Cancer Res
Huvudupphovsmän: Staal, Ben, Liu, Ying, Barnett, Daniel, Hsueh, Peter, He, Zonglin, Gao, ChongFeng, Partyka, Katie, Hurd, Mark W., Singhi, Aatur D., Drake, Richard R., Huang, Ying, Maitra, Anirban, Brand, Randall E., Haab, Brian B.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2019
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7246054/
https://ncbi.nlm.nih.gov/pubmed/30617132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-3310
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk